chr6-46858656-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001098518.2(ADGRF5):āc.3247A>Cā(p.Lys1083Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000473 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001098518.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRF5 | NM_001098518.2 | c.3247A>C | p.Lys1083Gln | missense_variant | 17/21 | ENST00000283296.12 | NP_001091988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRF5 | ENST00000283296.12 | c.3247A>C | p.Lys1083Gln | missense_variant | 17/21 | 1 | NM_001098518.2 | ENSP00000283296.7 | ||
ADGRF5 | ENST00000265417.7 | c.3247A>C | p.Lys1083Gln | missense_variant | 17/21 | 1 | ENSP00000265417.6 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000259 AC: 65AN: 251440Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135896
GnomAD4 exome AF: 0.000492 AC: 719AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.000485 AC XY: 353AN XY: 727246
GnomAD4 genome AF: 0.000296 AC: 45AN: 152260Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.3247A>C (p.K1083Q) alteration is located in exon 17 (coding exon 16) of the ADGRF5 gene. This alteration results from a A to C substitution at nucleotide position 3247, causing the lysine (K) at amino acid position 1083 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at